MediBeacon Inc.
Saint Louis, US · Founded 2012 · Delaware corporation · 3 known investors
MediBeacon develops biocompatible fluorescent tracer agents detected by skin sensors for clinical diagnostic applications including kidney function assessment and gastrointestinal permeability measurement. The company's medical technology platform serves clinicians managing patients with kidney disease and inflammatory bowel disorders, with additional applications in surgical visualization and preclinical research.
Founders & leadership
RD
Richard DorshowExecutive Officer, Director
TS
Terence SternExecutive Officer
SH
Steven HanleyExecutive Officer, Director
RL
Richard LytleDirector
CB
Charles BoltenDirector
JA
John A. FrielDirector
SM
Steven MillerDirector
DP
David PresentDirector
CP
Cherine PlumakerDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$16.1MraisedJan 2025 · 38 investors · Other Health CareRule 506(b)
▶$16.1MraisedJan 2025 · 38 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven MillerDirector
- David PresentDirector
- Richard DorshowExecutive Officer, Director
- Cherine PlumakerDirector
- Terence SternExecutive Officer
- Steven HanleyExecutive Officer, Director
- Offering amount
- $17.5M
- Amount sold
- $16.1M
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedMar 2023 · 11 investors · Other Health CareRule 506(b)
▶$1.8MraisedMar 2023 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven HanleyExecutive Officer, Director
- Steven MillerDirector
- Richard DorshowExecutive Officer, Director
- David PresentDirector
- Cherine PlumakerDirector
- Terence SternExecutive Officer
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.1MraisedJul 2022 · 25 investors · Other Health CareRule 506(b)
▶$8.1MraisedJul 2022 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard DorshowExecutive Officer, Director
- Terence SternExecutive Officer
- Cherine PlumakerDirector
- Steven HanleyExecutive Officer, Director
- Steven MillerDirector
- David PresentDirector
- Offering amount
- $8.1M
- Amount sold
- $8.1M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.3MraisedSep 2019 · 7 investors · Other Health CareRule 506(b)
▶$34.3MraisedSep 2019 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David PresentDirector
- Richard DorshowExecutive Officer, Director
- Terence SternExecutive Officer
- Steven MillerDirector
- Cherine PlumakerDirector
- Steven HanleyExecutive Officer, Director
- Offering amount
- $34.8M
- Amount sold
- $34.3M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedDec 2018 · 2 investors · Other Health CareRule 506(b)
▶$1.3MraisedDec 2018 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Cherine PlumakerDirector
- David PresentDirector
- Terence SternExecutive Officer
- Steven MillerDirector
- Steven HanleyExecutive Officer, Director
- Richard DorshowExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $1.3M
- Minimum investment
- $100K
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedJul 2018 · 11 investors · Other Health CareRule 506(b)
▶$2.1MraisedJul 2018 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven HanleyExecutive Officer, Director
- Steven MillerDirector
- David PresentDirector
- Terence SternExecutive Officer
- Richard DorshowExecutive Officer, Director
- Cherine PlumakerDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- Minimum investment
- $100K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.6MraisedJan 2018 · 22 investors · Other Health CareRule 506(b)
▶$4.6MraisedJan 2018 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Terence SternExecutive Officer
- Steven HanleyExecutive Officer, Director
- Steven MillerDirector
- Cherine PlumakerDirector
- David PresentDirector
- Richard DorshowExecutive Officer, Director
- Offering amount
- $5.2M
- Amount sold
- $4.6M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.2MraisedMar 2017 · 3 investors · Other Health CareRule 506(b)
▶$11.2MraisedMar 2017 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Cherine PlumakerDirector
- Richard DorshowExecutive Officer, Director
- David PresentDirector
- Steven MillerDirector
- Steve HanleyExecutive Officer, Director
- Terence SternExecutive Officer
- Offering amount
- $11.2M
- Amount sold
- $11.2M
- Sales commissions
- $510K
- Placement agents
- Bruce Roberts
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement Systemprnewswire.com · 2022
- Noninvasive, point-of-care kidney monitor startup raises $22.4M to get to market | Fierce Biotechfiercebiotech.com · 2015
- MediBeacon™ Inc. Enters into Agreement for $22.4 Million Investment to Bring Breakthrough Noninvasive Real-Time Kidney Monitoring to Market - Medibeaconmedibeacon.com · 2015